PDS Biotechnology officer reports stock options
Form 3 shows PDSB’s Principal Accounting Officer holding several option grants plus 1,124 common shares, with vesting schedules extending through 2030s.
Rhea-AI Filing Summary
PDS Biotechnology Corp (PDSB) reported that Principal Accounting Officer Janetta Trochimiuk holds multiple employee stock options and common shares. The options cover blocks of 70,000, 30,000, 30,000, 25,000, 31,117, 27,750, 5,000, and 10,000 shares of common stock at exercise prices ranging from $0.98 to $11.61, expiring between December 9, 2029 and January 12, 2036. Some options vest over four years with 25% on the first anniversary and the remainder in 36 equal monthly installments, while others are already fully vested and exercisable. She also directly holds 1,124 shares of PDS Biotechnology common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Trochimiuk Janetta
Role
Principal Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 228,867 contracts (Direct);
Common Stock — 1,124 shares (Direct)
Footnotes (5)
- F1. The option was granted on January 12, 2026, with 25% vesting on January 12, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- F2. The option was granted on June 12, 2025, with 25% vesting on June 12, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- F3. The option was granted on February 28, 2024, with 25% vesting on February 28, 2025 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- F4. The option was granted on January 4, 2023, with 25% vesting on January 4, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- F5. The options are fully vested and exercisable.
Key Figures
Direct common shares held: 1,124 shares
Stock option underlying shares: 70,000 shares
Stock option underlying shares: 30,000 shares
+5 more
8 metrics
Direct common shares held
1,124 shares
Direct ownership as of September 12, 2026
Stock option underlying shares
70,000 shares
Option at $0.98 exercise price, expiring January 12, 2036
Stock option underlying shares
30,000 shares
Option at $1.79 exercise price, expiring June 12, 2035
Stock option underlying shares
30,000 shares
Option at $5.87 exercise price, expiring February 28, 2034
Stock option underlying shares
25,000 shares
Option at $11.61 exercise price, expiring January 4, 2033
Fully vested option shares
31,117 shares
Option at $6.28 exercise price, fully vested, expiring January 19, 2032
Fully vested option shares
27,750 shares
Option at $2.43 exercise price, fully vested, expiring June 17, 2031
Fully vested option shares
10,000 shares
Option at $2.88 exercise price, fully vested, expiring December 9, 2029
Key Terms
Stock Option (Right to Buy), exercise price, vesting, Principal Accounting Officer
4 terms
Stock Option (Right to Buy) financial
"security title is listed as Stock Option (Right to Buy) on multiple entries"
exercise price financial
"each option includes an exercise price such as 0.9800 or 11.6100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% vesting on the first anniversary and remaining 75% vesting in 36 equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Principal Accounting Officer financial
"reporting person is identified with the title Principal Accounting Officer"
The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filing disclose about PDSB’s Principal Accounting Officer?
It discloses that PDSB’s Principal Accounting Officer, Janetta Trochimiuk, holds multiple employee stock options on common stock and directly owns 1,124 common shares as of September 12, 2026, with no reported purchases or sales in this filing.
How many PDSB stock options does Janetta Trochimiuk hold and at what exercise prices?
She holds separate stock options over 70,000, 30,000, 30,000, 25,000, 31,117, 27,750, 5,000, and 10,000 PDSB common shares, with exercise prices of $0.98, $1.79, $5.87, $11.61, $6.28, $2.43, $1.45, and $2.88 per share, respectively.
What are the vesting terms of the most recent PDSB stock option grant?
The option tied to 70,000 shares at an exercise price of $0.98 was granted on January 12, 2026, with 25% vesting on January 12, 2027 and the remaining 75% vesting in 36 equal monthly installments, subject to continued service.
Which PDSB stock options held by the Principal Accounting Officer are fully vested?
Footnote F5 states that certain options, including those covering 31,117, 27,750, 5,000, and 10,000 PDSB common shares at exercise prices of $6.28, $2.43, $1.45, and $2.88, are fully vested and exercisable.
When do the PDSB stock options reported on this Form 3 expire?
The reported PDSB stock options expire on dates ranging from December 9, 2029 to January 12, 2036, with each grant having its own specific expiration date tied to its original grant terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
